Quantification of Long-term Survival Benefit in a Comparative Oncology Clinical Study.
Where this comes from
- Record sourced from PubMed, PMID 29801103.
- Also identified by DOI 10.1001/jamaoncol.2018.0518 and PMC identifier 6145678.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study compares conventional hazard ratios and an alternative, clinically interpretable approach to quantify the long-term survival benefit in patients receiving chemotherapy with immunotherapy.
Medical subject headings
- Clinical Studies as Topic
- Kaplan-Meier Estimate
- Medical Oncology